Piper Jaffray Upgrades Threshold Pharmaceuticals (THLD) to Overweight

February 20, 2013 7:40 AM EST Send to a Friend
Get Alerts THLD Hot Sheet
Price: $4.47 -4.69%

Rating Summary:
    9 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 24 | New: 21
Trade THLD Now!
Join SI Premium – FREE
Piper Jaffray upgraded Threshold Pharmaceuticals (NASDAQ: THLD) from Neutral to Overweight with a price target of $10.00 (from $5.00).

For an analyst ratings summary and ratings history on Threshold Pharmaceuticals click here. For more ratings news on Threshold Pharmaceuticals click here.

Shares of Threshold Pharmaceuticals closed at $4.46 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Hot Upgrades, Upgrades

Related Entities

Piper Jaffray

Add Your Comment